Oxidative Stress and Iron Overload in Patient With Abnormal Haemoglobinopathy

NCT05586932 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2022-10-19

No results posted yet for this study

Summary

The effects of iron overload and oxidative stress and dyslipidemia on glucose level and thyroid function in patients with abnormal hemoglobinopathy. 2- Evaluation of MDA level as a marker of oxidative stress.

Conditions

  • Oxidative Stress in Patient With Haemoglobinopathy and Affect it of Endocrine System

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-01
Primary Completion
2023-12-01
Completion
2024-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05586932 on ClinicalTrials.gov